WELCOME TO G-FINDER

G-FINDER tracks public, private, and philanthropic funding of basic research and product development (R&D) for global health priorities.

The core focus of the project is neglected disease (ND) R&D funding. NDs are diseases that predominantly affect low- and middle-income countries and for which products are needed, but there is insufficient commercial incentive to stimulate R&D.

The survey also collects data about R&D funding for emerging infectious diseases (EIDs). The list of diseases included in the survey is based on the priority pathogens identified in the WHO R&D Blueprint.

This year, we are also inviting participants to provide data on their R&D funding for sexual and reproductive health (SRH) issues. The SRH issues included in the survey were identified as high priority areas by a group of international experts. The SRH survey is separate to the ND/EID survey, but accessible on the same platform.

Please provide data for both the ND/EID and the SRH surveys, if applicable.

The surveys are conducted by Policy Cures Research and funded by the Bill & Melinda Gates Foundation. For more information, please refer to the frequently asked questions.

G-FINDER reports

The neglected disease survey results are published and launched as yearly G-FINDER reports (see below). Data collected for other global health priorities will be reported separately:

- the EID survey results (analysing 2014-2017 funding data) will be published in June 2019, coinciding with the Global Health Security Conference in Sydney. We hope to publish EID funding data collected for 2018 at a later stage

- the SRH survey results (analysing 2018 funding data) will be published in early 2020.

G-FINDER Public Search Tool

All underlying data is freely available via the G-FINDER public search tool. Confidential industry data is aggregated and anonymised.

Site navigation

WELCOME TO G-FINDER

G-FINDER reports

G-FINDER Public Search Tool

Key dates

Footer information